Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-079-3 | CAS number: 949109-75-5
Endpoint summary
Administrative data
Description of key information
In a well conducted LD50 oral study in rats, 5 g/kg (bw) was adminstered by gavage to a group of 5 male and 5 female SD rats and observed for a period of 15 days for signs of lethality and other overt effects. During the study there were no treatment related effects and the LD50 > 5 g/kg (bw).
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- LD50 (oral, rat ) > 5000 mg/kg (bw).Reliability 2.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Quality of whole database:
- LD50 (dermal, rabbit) > 2000 mg/kg (bw). Reliability 2.
Additional information
In a well conducted LD50 oral study in rats, 5 g/kg (bw) was adminstered by gavage to a group of 5 male and 5 female SD rats and observed for a period of 15 days for signs of lethality and other overt effects. During the study there were no treatment related effects and the LD50 > 5 g/kg (bw).
In a well conducted acute dermal study in white New Zealand Albino Rabbits which were dosed 2g/kg (bw). No substance related effects were reported. The LD50 was taken to be greater than 2 g/kg (bw).
Justification for selection of acute toxicity – oral endpoint
Good quality key study
Justification for classification or non-classification
On the basis of the results from the acute oral and dermal study there is no requirement to classify under CLP Regulation (1272/2008) or the Dangerous Substances Directive (67/548/EEC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
